Research
Hormonal
Genetic loss-of-function variants in the GIP receptor are associated with lower body mass index (BMI) and protection against obesity in humans.
Large-scale genetic studies show that people with naturally reduced GIP receptor function tend to have lower body weight. This suggests that therapies designed to block or antagonize the GIP receptor could be effective for treating obesity and type 2 diabetes.
StrongSupportsVERY_HIGH confidence
Here, phenotypic studies combined with genome-wide association studies (GWAS) in human carriers of LoF variants have supported protection against obesity [119]. Thus, a GWAS study combining data from 718,734 individuals identified variants of the GIPR gene among the few associated with a lower BMI [119].
Why this rating
Based on a massive GWAS study of 718,734 individuals, providing robust population-level evidence.
Source
GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology
Mette M. Rosenkilde et al. · Peptides · 2024
DOI 10.1016/j.peptides.2024.171212
narrative_reviewCited 15×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →